Influence of the COVID-19 pandemic on the achievement of guideline targets for HbA1c, blood pressure, and LDL cholesterol in people with diabetes in Japan

Objective In this study, we investigated whether the COVID-19 pandemic affected achievement of guideline targets for HbA1c, blood pressure (BP), and low-density lipoprotein (LDL) cholesterol in people with diabetes mellitus (DM). Materials and methods Data for 556 people with DM who were treated reg...

Full description

Saved in:
Bibliographic Details
Published in:Diabetology international 2024-07, Vol.15 (3), p.507-517
Main Authors: Kuwajima, Shingo, Itoh, Takahito, Sato, Tatsuya, Ino, Shoya, Shibata, Satoru, Ohno, Kouhei, Hotta, Hiroyuki, Matsumoto, Tomoaki, Ooiwa, Hitoshi, Kubo, Hirofumi, Miki, Takayuki
Format: Article
Language:English
Subjects:
Blood pressure
Cardiovascular disease
Cholesterol
Coronary artery disease
COVID-19
Diabetes
Diabetes mellitus
Endocrinology
Heart diseases
Low density lipoprotein
Medicine
Medicine & Public Health
Metabolic Diseases
Original Article
Pandemics
Therapeutic targets
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective In this study, we investigated whether the COVID-19 pandemic affected achievement of guideline targets for HbA1c, blood pressure (BP), and low-density lipoprotein (LDL) cholesterol in people with diabetes mellitus (DM). Materials and methods Data for 556 people with DM who were treated regularly for 4 years before and during the COVID-19 pandemic in Japan were analyzed in this retrospective study. Achieved targets were defined as HbA1c 
ISSN:2190-1678
2190-1686
DOI:10.1007/s13340-024-00715-8